Interrelation of the FTO rs9939609 SNP and the DAT1 rs27072 SNP with Body Mass Index and Degree of Obesity in the Population of Yakuts

ORIGINAL ARTICLE
Nadezhda I. Pavlova, Khariton A. Kurtanov, Aleksandra T. Diakonova, Natalia A. Solovyeva, Ljubov' Ah. Sydykova, Tuiara N. Aleksandrova, Yulia A. Solovyeva

 
International Journal of Biomedicine. 2019;9(3):210-215.
DOI: 10.21103/Article9(3)_OA4
Originally published September 15, 2019  

Abstract: 

The purpose of the present study was to evaluate a possible interrelation of the FTO rs9939609 SNP and the DAT1 rs27072 SNP with BMI and grade of obesity in the population of Yakuts
Materials and Methods: A total of 191 people of Yakut nationality were tested (143 women and 48 men). Two groups of subjects were formed: the control group (CG) with BMI˂25 kg/m2 and the obesity group (OG) with BMI≥30 kg/m2. The study of the FTO rs9939609 SNP and the DAT1 rs27072 SNP was performed by PCR and restriction fragment length polymorphism.
Results: According to the results obtained from all persons surveyed, the frequency of the A risk allele of the FTO rs9939609 SNP was 27% with the AA genotype frequency of 9.4%. Analysis of the distribution of alleles and genotypes of the DAT1 rs27072 SNP showed the predominance of the wild-type G allele (90.8%) and the GG genotype in all groups (82.7%). Thus, in the Yakut population, a reliable relationship was found between the carriage of the A risk allele of the FTO SNP rs9939609 SNP with obesity and the degree of obesity. A significantly higher BMI was found in carriers of the wild-type G allele of the DAT1 rs27072 SNP, both in the heterozygous and homozygous forms than in the carriers of the homozygous AA genotype, which is probably related to the small number of people studied and requires careful research on larger samples of populations of Yakutia.

Keywords: 
BMI • obesity • FTO • DAT1 • eating disorders
References: 
  1. O’Rahilly S, Farooqi IS. Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes. 2008;57(11): 2905-10. doi: 10.2337/db08-0210.
  2. World Health Organization. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  3. Panin LE. [Homeostasis and the problems of circumpolar medicine. (Methodological Aspects of Adaptation)]. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 2010;3(30):6-11. [Article in Russian].
  4. Darbasov VR, Baisheva VM, Fedorova EJa, Ohlopkov MN. [Features of the development of the food market of Yakutia: assessment of the level of food consumption and food supply of the population]. Regional Economics and Management: electronic scientific journal. 2017; 2(50). [Article in Russian].
  5. Bojko NN.  [Wake up the internal doctor]. Moscow: Interregional public fund “Home country”; 2011. [In Russian].
  6. Hebebrand J, Sommerlad C, Geller F, Görg T, Hinney A. The genetics of obesity: practical implications. Int J Obes Relat Metab Disord. 2001;25 Suppl 1:S10–8.
  7. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826): 889–94.
  8. Prakash J, Mittal B, Srivastava A, Awasthi S, Srivastava N. Association of FTO rs9939609 SNP with Obesity and Obesity-Associated Phenotypes in a North Indian Population. Oman Med J. 2016;31(2):99-106. doi: 10.5001/omj.2016.20
  9. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318(5855):1469–72. doi: 10.1126/science.1151710.
  10. Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring). 2008;16(8):1961–5. doi: 10.1038/oby.2008.318.
  11. Wardle J, Llewellyn C, Sanderson S, Plomin R. The FTO gene and measured food intake in children. Int J Obes (Lond). 2009;33(1):42–5. doi: 10.1038/ijo.2008.174.
  12. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008;93(9):3640–3. doi: 10.1210/jc.2008-0472.
  13. den Hoed M, Westerterp-Plantenga MS, Bouwman FG, Mariman EC, Westerterp KR. Postprandial responses in hunger and satiety are associated with the rs9939609 single nucleotide polymorphism in FTO. Am J Clin Nutr.2009;90(5):1426–32. doi: 10.3945/ajcn.2009.28053.
  14. Tanofsky-Kraff M, Han JC, Anandalingam K, Shomaker LB, Columbo KM, Wolkoff LE, et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am J Clin Nutr. 2009;90(6):1483-8. doi: 10.3945/ajcn.2009.28439.
  15. Cecil JE, Tavendale R, Watt P, Hetherington MM Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008; 359(24):2558-66. doi: 10.1056/NEJMoa0803839.
  16. Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, McCarthy MI, et al. The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr. 2008;88(4):971–8.
  17. Novikova EA, Bairova TA, Rychkova LV. [Correlation of the 48bp VNTR locus of DRD4 gene with overweight/obesity]. Acta Biomedica Scientifica. 2017;2(5(1)):63-68 doi: 10.12737/article_59e85bc95a4e77.95444674. [Article in Russian],
  18. Salatino-Oliveira A, Rohde LA, Hutz MH. The dopamine transporter role in psychiatric phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2018;177(2):211-231. doi: 10.1002/ajmg.b.32578.
  19. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage. 2003;19(4):1709–15.
  20. Norgren R, Hajnal A, Mungarndee SS. Gustatory reward and the nucleus accumbens. Physiol Behav. 2006;89(4):531–5.
  21. Haddley K, Vasiliou AS, Ali FR, Paredes UM, Bubb VJ, Quinn JP. Molecular genetics of monoamine transporters: relevance to brain disorders. Neurochem Res. 2008;33(4):652–67.
  22. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially‐dimorphic TaqI RFLPs. Brain Res Mol Brain Res. 1992;15(1-2):161-6.
  23. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry. 1997; 41(3):299-304. doi:10.1111/j.1530-0277.2011.01509.x.
  24. Diakonova AT, Pavlova NI, Solovyeva NA, Varlamova MA, Alexandrova TN, Kurtanov KhA. Molecular-genetic analysis of the connection of the SLC6A3 gene with nicotine addiction in Yakutia. Yakut Medical Journal. 2018;4(64):6-9 doi 10.25789/YMJ.2018.64.01
  25. Ohmoto M, Takahashi T, Kubota Y, Kobayashi S,  Mitsumoto Y. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population. BMC Genet. 2014;15:151. doi: 10.1186/s12863-014-0151-2.
  26. Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, et al. Eating disorders with binge-eating behaviour are associated with the s allele of the 3'-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci. 2004;29(2):134-7.

Download Article
Received July 25, 2019.
Accepted September 10, 2019.
©2019 International Medical Research and Development Corporation.